ArticleFrontiers in bioengineering and biotechnology2022
Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.
Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.